These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 170219)

  • 41. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T lymphocyte requirement for MSV tumour prevention or regression.
    Collavo D; Colombatti A; Chieco-Bianchi L
    Nature; 1974 May; 249(453):169-70. PubMed ID: 4545519
    [No Abstract]   [Full Text] [Related]  

  • 43. Genetic association of the humoral and cellular immune responses of rats to Moloney sarcomas.
    Veit BC; Jones JM; Miller GA; Feldman JD
    Int J Cancer; 1977 Jan; 19(1):97-106. PubMed ID: 401773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
    Basombrio MA
    Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
    [No Abstract]   [Full Text] [Related]  

  • 45. Evidence for the horizontal acquisition of murine AKR virogenes by recent horizontal infection of the germ line.
    O'Brien SJ; Moore JL; Martin MA; Womack JE
    J Exp Med; 1982 Apr; 155(4):1120-23. PubMed ID: 6278048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-dependent regression of M-MSV tumors in CBA/H mice: requirement for a macrophage-adherent cell population.
    Stutman O
    Adv Exp Med Biol; 1976; 73 Pt B():371-8. PubMed ID: 998400
    [No Abstract]   [Full Text] [Related]  

  • 47. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
    Leclerc JC; Gomard E; Levy JP
    Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of pseudotype on Abelson virus and Kirsten sarcoma virus-induced leukemia.
    Scher CD
    J Exp Med; 1978 Apr; 147(4):1044-53. PubMed ID: 206644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumour-associated transplantation antigens of neoplasms induced by a naturally occurring murine sarcoma virus (FBJ-MSV).
    Jones DB; Moore M
    Br J Cancer; 1973 Jun; 27(6):415-26. PubMed ID: 4516007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The integration sites of endogenous and exogenous Moloney murine leukemia virus.
    van der Putten H; Terwindt E; Berns A; Jaenisch R
    Cell; 1979 Sep; 18(1):109-16. PubMed ID: 509516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex and H-2 haplotype control the resistance of CBA-BALB hybrids to the induction of T cell lymphoma by Moloney leukemia virus.
    Storch TG; Chused TM
    J Immunol; 1984 Nov; 133(5):2797-800. PubMed ID: 6332861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge.
    Holden HT; Kirchner H; Herberman RB
    J Immunol; 1975 Aug; 115(2):327-31. PubMed ID: 168259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate.
    Jasmin C; Chermann JC; Herve G; Teze A; Souchay P; Boy-Loustau C; Raybaud N; Sinoussi F; Raynaud M
    J Natl Cancer Inst; 1974 Aug; 53(2):469-74. PubMed ID: 4367244
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice.
    Kastrukoff LF; Lau AS; Puterman ML
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():613-21. PubMed ID: 3007658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcoma.
    Giuliani F; Bellini O; Casazza AM; Formelli F; Savi G; Di Marco A
    Eur J Cancer (1965); 1978 May; 14(5):555-66. PubMed ID: 206445
    [No Abstract]   [Full Text] [Related]  

  • 56. Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c times AKR cross: a genetic analysis.
    Lilly F; Duran-Reynals ML; Rowe WP
    J Exp Med; 1975 Apr; 141(4):882-9. PubMed ID: 165256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement by asbestos of oncogenesis by Moloney murine sarcoma virus in CBA mice.
    Kanazawa K; Yamamoto T; Yuasa Y
    Int J Cancer; 1979 Jun; 23(6):866-74. PubMed ID: 223995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
    Powell TJ; Spann R; Nguyenduc M; Lamon EW
    J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restriction of C-type viral antigen in H-2/Fv-1 syngeneic mouse somatic cell hybrids.
    Kuzumaki N; Hilgers J; Moerkerk P; Ber R; Asjö B; Wiener F; Klein G
    Intervirology; 1980; 13(4):201-8. PubMed ID: 6248481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.